家庭醫學科

Medicine & Life Sciences

1. Population 41%
2. Glucose 38%
3. Non-alcoholic Fatty Liver Disease 35%
4. Glucose Intolerance 26%
5. Sleep 26%
6. Fasting 26%
7. Obesity 24%
8. Insulin Resistance 23%
9. Blood Pressure 22%
10. Hypertension 22%
11. Body Mass Index 18%
12. Serum 18%
13. Prediabetic State 16%
14. Orthostatic Hypotension 16%
15. Students 15%
16. Overweight 15%
17. Body Fat Distribution 15%
18. Diabetes Mellitus 15%
19. Magic 15%
20. Lipids 15%
21. Ankle 14%
22. Arm 14%
23. Prehypertension 14%
24. Elderly 14%
25. Confidence Intervals 14%
26. Exercise 13%
27. alpha-2-HS-Glycoprotein 13%
28. HDL Cholesterol 13%
29. Insulin 12%
30. Adipose Tissue 12%
31. Regression Analysis 12%
32. Bone Density 11%
33. Gallstones 11%
34. Streptozocin 11%
35. Cardiovascular Diseases 11%
36. Education 11%
37. Cross-Sectional Studies 10%
38. Quality of Life 10%
39. Cholesterol 10%
40. Odds Ratio 10%
41. Logistic Models 9%
42. Randomized Controlled Trials 9%
43. Health 9%
44. Cohort Studies 9%
45. Uric Acid 9%
46. Triglycerides 9%
47. Hypoglycemic Agents 9%
48. Smoking 9%
49. Depression 9%
50. Outpatients 8%
51. Delivery of Health Care 8%
52. Weights and Measures 8%
53. Linear Models 7%
54. Transitional Cell Carcinoma 7%
55. Esophagitis 7%
56. Mastication 7%
57. Multimorbidity 7%
58. cardiotrophin 1 7%
59. Glycated Hemoglobin A 7%
60. Chronic Renal Insufficiency 7%
61. Dipeptidyl-Peptidase IV Inhibitors 7%
62. Kidney 7%
63. Waist-Hip Ratio 6%
64. Weight Loss 6%
65. Longitudinal Studies 6%
66. Areca 6%
67. Waist Circumference 6%
68. Alleles 6%
69. University Hospitals 6%
70. Adiponectin 6%
71. Metformin 6%
72. Activities of Daily Living 6%
73. Neuroticism 6%
74. SARS Virus 6%
75. Stroke 6%
76. Drinking 6%
77. Liver 6%
78. Fibrinogen 6%
79. Costs and Cost Analysis 6%
80. Potentially Inappropriate Medication List 6%
81. Smokers 6%
82. Urine 6%
83. Advance Care Planning 6%
84. Adenoma 6%
85. Baroreflex 5%
86. Urologic Diseases 5%
87. Hip Fractures 5%